A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2024 Sep 28

PMID 39339158

Authors

Jagadeesh Rajaram

Lokesh Kumar Mende

Yaswanth Kuthati

Affiliations

Soon will be listed here.

Abstract

Natural photosensitizers (PS) are compounds derived from nature, with photodynamic properties. Natural PSs have a similar action to that of commercial PSs, where cancer cell death occurs by necrosis, apoptosis, and autophagy through ROS generation. Natural PSs have garnered great interest over the last few decades because of their high biocompatibility and good photoactivity. Specific wavelengths could cause phytochemicals to produce harmful ROS for photodynamic therapy (PDT). However, natural PSs have some shortcomings, such as reduced solubility and lower uptake, making them less appropriate for PDT. Nanotechnology offers an opportunity to develop suitable carriers for various natural PSs for PDT applications. Various nanoparticles have been developed to improve the outcome with enhanced solubility, optical adsorption, and tumor targeting. Multidrug resistance (MDR) is a phenomenon in which tumor cells develop resistance to a wide range of structurally and functionally unrelated drugs. Over the last decade, several researchers have extensively studied the effect of natural PS-based photodynamic treatment (PDT) on MDR cells. Though the outcomes of clinical trials for natural PSs were inconclusive, significant advancement is still required before PSs can be used as a PDT agent for treating MDR tumors. This review addresses the increasing literature on MDR tumor progression and the efficacy of PDT, emphasizing the importance of developing new nano-based natural PSs in the fight against MDR that have the required features for an MDR tumor photosensitizing regimen.

Citing Articles

Recent Advances in Glutathione Depletion-Enhanced Porphyrin-Based nMOFs for Photodynamic Therapy.

Gong B, Zhang Q, Chen J, Qu Y, Luo X, Wang W Pharmaceutics. 2025; 17(2).

PMID: 40006611 PMC: 11860060. DOI: 10.3390/pharmaceutics17020244.

Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy.

Qi C, Chen J, Qu Y, Luo X, Wang W, Zheng X Pharmaceutics. 2025; 16(12.

PMID: 39771603 PMC: 11678282. DOI: 10.3390/pharmaceutics16121625.

Cell Death by Metals: Diversity of Phenomena vs. Distinctive Categories.

Shtil A, Chernov K, Tsymbal S Cancers (Basel). 2024; 16(22).

PMID: 39594722 PMC: 11593088. DOI: 10.3390/cancers16223767.

NRF2 Modulators of Plant Origin and Their Ability to Overcome Multidrug Resistance in Cancers.

Wadowski P, Juszczak M, Wozniak K Int J Mol Sci. 2024; 25(21).

PMID: 39519053 PMC: 11547051. DOI: 10.3390/ijms252111500.

References

Famta P, Shah S, Chatterjee E, Singh H, Dey B, Guru S . Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms. Curr Res Pharmacol Drug Discov. 2021; 2:100054. PMC: 8663938. DOI: 10.1016/j.crphar.2021.100054. View

Chehelgerdi M, Chehelgerdi M, Allela O, Pecho R, Jayasankar N, Rao D . Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023; 22(1):169. PMC: 10561438. DOI: 10.1186/s12943-023-01865-0. View

Lu K, He C, Lin W . A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers. J Am Chem Soc. 2015; 137(24):7600-3. PMC: 4691355. DOI: 10.1021/jacs.5b04069. View

Di Martino A, Pavelkova A, Postnikov P, Sedlarik V . Enhancement of 5-aminolevulinic acid phototoxicity by encapsulation in polysaccharides based nanocomplexes for photodynamic therapy application. J Photochem Photobiol B. 2017; 175:226-234. DOI: 10.1016/j.jphotobiol.2017.08.010. View

Wen Y, Jia Q, Nan F, Zheng X, Liu W, Wu J . Pheophytin Derived Near-Infrared-Light Responsive Carbon Dot Assembly as a New Phototheranotic Agent for Bioimaging and Photodynamic Therapy. Chem Asian J. 2019; 14(12):2162-2168. DOI: 10.1002/asia.201900416. View

Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez A, Martinez-Perez A, Rodrigo J, Garcia-Pedrero J . Chemo-Immunotherapy: A New Trend in Cancer Treatment. Cancers (Basel). 2023; 15(11). PMC: 10252089. DOI: 10.3390/cancers15112912. View

Konan Y, Berton M, Gurny R, Allemann E . Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci. 2003; 18(3-4):241-9. DOI: 10.1016/s0928-0987(03)00017-4. View

Wang H, Jia Q, Liu W, Nan F, Zheng X, Ding Y . Hypocrellin Derivative-Loaded Calcium Phosphate Nanorods as NIR Light-Triggered Phototheranostic Agents with Enhanced Tumor Accumulation for Cancer Therapy. ChemMedChem. 2019; 15(2):177-181. DOI: 10.1002/cmdc.201900512. View

Sun M, Zhang Y, He Y, Xiong M, Huang H, Pei S . Green synthesis of carrier-free curcumin nanodrugs for light-activated breast cancer photodynamic therapy. Colloids Surf B Biointerfaces. 2019; 180:313-318. DOI: 10.1016/j.colsurfb.2019.04.061. View

10.

Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

11.

Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J . The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022; 12:985363. PMC: 9597512. DOI: 10.3389/fonc.2022.985363. View

12.

Deng G, Sun Z, Li S, Peng X, Li W, Zhou L . Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. ACS Nano. 2018; 12(12):12096-12108. DOI: 10.1021/acsnano.8b05292. View

13.

Yue J, Mei Q, Wang P, Miao P, Dong W, Li L . Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy. J Nanobiotechnology. 2022; 20(1):181. PMC: 8991811. DOI: 10.1186/s12951-022-01388-8. View

14.

Cao X, Hou J, An Q, Assaraf Y, Wang X . Towards the overcoming of anticancer drug resistance mediated by p53 mutations. Drug Resist Updat. 2019; 49:100671. DOI: 10.1016/j.drup.2019.100671. View

15.

Montaseri H, Kruger C, Abrahamse H . Recent Advances in Porphyrin-Based Inorganic Nanoparticles for Cancer Treatment. Int J Mol Sci. 2020; 21(9). PMC: 7247422. DOI: 10.3390/ijms21093358. View

16.

Qiu H, Kim M, Penjweini R, Finlay J, Busch T, Wang T . A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy. Photochem Photobiol. 2017; 93(4):1115-1122. PMC: 5500427. DOI: 10.1111/php.12719. View

17.

Moret F, Menilli L, Battan M, Tedesco D, Columbaro M, Guerrini A . Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy. Pharmaceutics. 2021; 13(8). PMC: 8399365. DOI: 10.3390/pharmaceutics13081130. View

18.

Kuang G, Zhang Q, He S, Liu Y . Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy. RSC Adv. 2022; 10(41):24624-24630. PMC: 9055143. DOI: 10.1039/d0ra04778c. View

19.

Yang C, Huang K, Wang Y, Shaw J . A Review of Bacteriochlorophyllides: Chemical Structures and Applications. Molecules. 2021; 26(5). PMC: 7957641. DOI: 10.3390/molecules26051293. View

20.

Singh S, Gomez H, Thakkar S, Singh S, Parihar A . Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. Int J Mol Sci. 2023; 24(5). PMC: 10002572. DOI: 10.3390/ijms24054722. View